J&J Sues HHS over Move to Block 340B Rebate Model
- November 15, 2024
The Health Resources and Services Administration (HRSA) lacks statutory authority to block Johnson & Johnson (J&J) from implementing a new rebate-model for obtaining drug discounts under the 340B program, according to a lawsuit the company filed November 12 against the Department of Health and Humans Services (HHS).
ARTICLE TAGS
You must be logged in to access this content.